Navigation Links
IMPAKT -- Translational research breast cancer conference
Date:4/11/2013

"What is discussed at IMPAKT can directly lead to new ways of designing trials that would hopefully lead to new protocols in the course of the next few years and could change outcome for patients."

Andrew Tutt and Peter Dubsky, IMPAKT 2013 Co-Chairs

IMPAKT 2013 will build on topics discussed in previous years and will focus specifically on the following areas Watch the video here[http://www.youtube.com/watch?v=X_anpC5WZPg]:

  • Breast cancer heterogeneity - Mechanisms, capturing, and clinical implications
    • How much is there at the start and how much happens over time
    • Can host immune response beat tumour heterogeneity or does it complicate outcomes?
    • Dissemination and organ specific metastasis of breast cancer: How does heterogeneity play a role?
    • Can heterogeneity in advanced breast cancer be captured by molecular imaging?
  • Targeting the PI3K/AKT/mTOR axes in breast cancer: targets, trials and biomarkers
  • Cancer reprogramming induced by treatment: Is it a problem and can we predict and inhibit it in the clinic?
  • Biomarker driven neoadjuvant trials in breast cancer
  • How to avoid false positive and false negative results in the assessment of oestrogen and progesterone receptor status
  • In a world of breast cancer heterogeneity is the biopsy of metastasis helpful or distracting?
  • Integrating breast cancer genomics and proteomics - shooting for the moon

The full conference programme is available at http://www.esmo.org/events/breast-2013-impakt/program.html

The 2013 Press Programme will capture the very essence of the IMPAKT conference, where the ultimate goal is to improve breast cancer outcome through translational research, i.e. new techniques, new concepts on the cutting edge to change the clinic as soo
'/>"/>

Contact: ESMO PRess Office
media@esmo.org
European Society for Medical Oncology
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Fourth IMPAKT Breast Cancer Conference
2. Hot topics in translational bone research at IOF-ESCEO 3rd Pre-Clinical Symposium
3. Autism Speaks and SAGE® Labs develop rat models for translational autism research
4. Elsevier launches new open access journal: Applied and Translational Genomics
5. BUSM researchers identify novel approach to study COPD and treatment efficacy
6. LSUHSC research discovers new drug target for metastatic breast cancer
7. Researchers call for marine observation network
8. Biofilms help Salmonella survive hostile conditions, Virginia Tech researchers say
9. Feinstein Institute collaborates with GSK, UPenn, MIT to research bodys electrical impulses
10. U-M researchers find new way to clear cholesterol from the blood
11. New cutting-edge cell research will lead to safer medical experiments on humans
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2015)... 2015 ATL Technology, LLC, a top provider of ... single use solutions, headquartered in Springville, Utah ... California corporation with locations in ... Costa Rica ). This acquisition will incorporate ... with ATL Technology,s existing facility in Costa Rica ...
(Date:6/25/2015)... , June 25, 2015  TAKE Solutions Ltd., ... patent by the United States Patent and Trademark Office ... This process leverages TAKE Solutions, Clinical Accelerators to reduce ... 50% (when compared to standardization without the accelerators), thus ... At the heart of the ...
(Date:6/24/2015)... SAN JOSE, Calif. , June 24, 2015 ... leading developer of human interface solutions, today announced ... fingerprint sensor to provide secure authentication for its ... Having recently reached more than 200 million shipments ... shipment with Sharp reinforces Synaptics, strength, scalability and ...
Breaking Biology News(10 mins):ATL Technology Announces Acquisition of MedConx, Inc. and Expanded Global Footprint 2TAKE Solutions Awarded Patent By USPTO 2Synaptics Brings Natural ID Technology to Sharp's Newest Flagship Smartphone 2
... genetic disease, based on cells' own ability to correct themselves, ... annual conference of the European Society of Human Genetics in ... replacing a faulty gene (commonly referred to as gene therapy) ... that already exists in human biology. , Professor Brunhilde Wirth, ...
... Researchers have a new understanding of the process cells ... with exactly one copy of each chromosome ?a process ... as miscarriages and mental retardation. The new work reveals ... precisely the moment of meiosis ?the specialized cell division ...
... can be the key either preventing or promoting the cell ... work provides proof in principle that pharmacological inhibition of calpain ... this is not desirable, such as in neuronal cells of ... cancer cells where this is clearly a very desirable outcome," ...
Cached Biology News:'Smart' genetic therapy helps the body to heal itself 2'Smart' genetic therapy helps the body to heal itself 3'Smart' genetic therapy helps the body to heal itself 4What controls stickiness of 'smart' chromosomal glue 2What controls stickiness of 'smart' chromosomal glue 3What controls stickiness of 'smart' chromosomal glue 4Protein's role in regulating cell death sets direction for cancer research 2
(Date:6/30/2015)... ... June 30, 2015 , ... Students and faculty from ... first half of “Integrative Biotechnology,” an applied biotechnology course team-taught by faculty members ... course combines students from both universities and is taught on both continents. , ...
(Date:6/30/2015)... , ... June 30, 2015 , ... ... hosting a webinar to provide advanced scientific research into new classes of Nanoscale ... and energy. Touted as 'the wonder material of the 21st Century' by ...
(Date:6/30/2015)... 2015  Juniper Pharmaceuticals, Inc. (Nasdaq: JNP ), ... that address unmet medical needs in women,s health, ... will present at the Cantor Fitzgerald Inaugural Healthcare ... , 4:45 PM EDTLocation: , Le Parker Meridien ... www.juniperpharma.com, under  ,Investor, or  click here ...
(Date:6/30/2015)... ... June 30, 2015 , ... uBiome and OpenBiome Partner for ... of fecal microbiota transplantation in C. difficile patients. , SAN FRANCISCO, uBiome and ... fecal microbiota transplantation (FMT) as a treatment for Clostridium difficile infections (C. diff). ...
Breaking Biology Technology:Rivier University and Beijing City University Academic and Cultural Exchanges Begin 2How Graphene–based Nanomaterials and Films Revolutionize Science Explained in July 9 Webinar Hosted by Park Systems 2How Graphene–based Nanomaterials and Films Revolutionize Science Explained in July 9 Webinar Hosted by Park Systems 3How Graphene–based Nanomaterials and Films Revolutionize Science Explained in July 9 Webinar Hosted by Park Systems 4Juniper Pharmaceuticals to Present at Cantor Fitzgerald Inaugural Healthcare Conference on July 8, 2015 2uBiome and OpenBiome Partner for Microbiome Study in FMT Patients 2uBiome and OpenBiome Partner for Microbiome Study in FMT Patients 3
... NewCardio, Inc., (OTC BB: NWCI) a cardiac ... its recent medical and technical submissions have been ... International Conference of the IEEE Engineering in Medicine ... two papers: ,Wireless Monitoring of Reconstructed 12-Lead ECG ...
... June 16, 2011 Dendreon Corporation (Nasdaq: DNDN ) ... Investor Program in London on June 21, 2011 at 9:30 a.m. ... live and available for replay from Dendreon,s website, www.dendreon.com . ... will be archived on the site following the presentation. To access ...
... AppTec announced today that it has been selected as one ... by China,s Ministry of Commerce. The list was announced at ... Nanjing on June 10, 2011. Dr. Ge Li, Chairman and ... Ten Contributor to China,s Outsourcing Industry. The conference ...
Cached Biology Technology:NewCardio Selected to Present at 33rd Annual International Conference of the IEEE Engineering in Medicine and Biology Society 2NewCardio Selected to Present at 33rd Annual International Conference of the IEEE Engineering in Medicine and Biology Society 3NewCardio Selected to Present at 33rd Annual International Conference of the IEEE Engineering in Medicine and Biology Society 4
... Panels were designed for full-length gene cloning ... to identify the desired cDNA clone. The ... 96-well "Master Plate," where each well contains ... the positive well(s) by gel electrophoresis of ...
... The ProteinChip beta-amyloid Multipeptide Kit, ... Systems, makes detecting a variety of ... than ever before. - Clinical neuroscience ... after drug treatment - Correlate beta-amyloid ...
Formula variant: With the macro- and micronutrients as described by Lloyd and McCown (1981). Preparation Quantity Equivalency: Formulated to contain 2.3 grams of powder per liter of medium. Physical ...
... and MDS Sciex present the 4000 ... performance hybrid triple quadrupole/linear ion trap ... drug development or proteomics researcher. Innovative ... the leaders in mass spectrometry brings ...
Biology Products: